Exome Asset Management LLC Vera Therapeutics, Inc. Transaction History
Exome Asset Management LLC
- $135 Billion
- Q2 2025
A detailed history of Exome Asset Management LLC transactions in Vera Therapeutics, Inc. stock. As of the latest transaction made, Exome Asset Management LLC holds 76,700 shares of VERA stock, worth $1.93 Million. This represents 1.34% of its overall portfolio holdings.
Number of Shares
76,700
Previous 76,700
-0.0%
Holding current value
$1.93 Million
Previous $1.81 Billion
-0.0%
% of portfolio
1.34%
Previous 1.34%
Shares
1 transactions
Others Institutions Holding VERA
# of Institutions
203Shares Held
65.3MCall Options Held
1.58MPut Options Held
358K-
Avoro Capital Advisors LLC New York, NY6.3MShares$159 Million2.71% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD4.48MShares$113 Million0.01% of portfolio
-
Kynam Capital Management, LP Princeton, NJ3.43MShares$86.3 Million9.64% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY3.35MShares$84.3 Million1.81% of portfolio
-
Black Rock Inc. New York, NY3.34MShares$84.1 Million0.0% of portfolio
About Vera Therapeutics, Inc.
- Ticker VERA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 27,042,300
- Market Cap $681M
- Description
- Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immunological diseases in the United States. Its lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection that is in Phase IIb clinical trial for patients with ...